How to preserve residual renal function in patients with chronic kidney disease and on dialysis?

Nephrology Dialysis Transplantation

Volumn 21, Issue SUPPL. 2, 2006, Pages

  Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chronic kidney disease; Dialysis dose; Glomerular filtration rate; Haemodialysis; Poritoneal dialysis; Residual GFR

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; CIMETIDINE; CONTRAST MEDIUM; CREATININE; CYCLOSPORIN A; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INULIN; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RAMIPRIL; TACROLIMUS;

ACCURACY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIALYSIS MEMBRANE; DRUG EFFICACY; DRUG MEGADOSE; FLUID THERAPY; FUNCTION TEST; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; INULIN CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS; PERITONITIS; PREDICTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; URINALYSIS;

GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; METABOLIC CLEARANCE RATE; PERITONEAL DIALYSIS;

EID: 33745782946     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl137     Document Type: Review

References (49)

1. National Kidney Foundation. K/DOQ1 clinical practical guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266
2. Smith HW. The reliability of inulin as a measure of glomerular filtration. In: SmitS HW, ed. The kidney: structure and function in health and disease. Oxford University Press, New York: 1951; 231-238
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
4. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838
5. Shannon JA. The renal excretion of creatinine in man. J Clin Invest 1935; 14: 403-410
6. Spencer K. Analytical reviews in clinical biochemistry; the estimation of creatinine. Ann Clin Bichem 1986; 23: 1-25
7. Ixkes MC, Koompan MG, van Acker BA, Weber JA, Arisz L. Cimetidine improves GFR-estimation by the Cockcroft and Gault formula. Clin Nephrol 1997; 47: 229-236
8. Kemperman FAW, Silberbusch J, Slaats EH et al. Estimation of the glomerular filtration rate in NIDDM patients from plasma creatinine concentration after cimetidine administration. Diabetes Care 1998; 21: 216-220
9. Kemperman FAW, Silberbusch J, Slaats EH et al. Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2. Clin Nephrol 2000; 54: 255-260
10. Kemperman FAW, Surachno S, Krediet RT, Arisz L. Cimetidine improves prediction of the glomerular filtration rate by the Cockcroft and Gault formula in renal transplant patients. Transplantation 2002; 73: 770-774
11. Kemperman FAW, Krediet RT, Arisz L. Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron 2002; 91: 547-558
12. Levey AS, Bosch JP, Lewis JB, Green T, Rogers N, Roth D, for the modification of diet in renal disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470
13. Poggio E, Wang X, Greene T, van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft and Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-466
14. Simonsen O, Grubb A, Thyssel H. The blood serum concentration of cystatin-C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 1985; 45: 97-101
15. Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin-C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-2031
16. Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 1984; 66: 613-619
17. Klassen DK, Weir MR, Buddemeyer EU. Simultaneous measurement of glomerular filtration rate by two radio isotopic methods in patients without renal impairment. J Am Soc Nephrol 1992; 3: 108-112
18. Van Acker BA, Koomen GC, Koopman MG, de Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992; 340: 1326-1329
19. Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with CAPD. J Am Soc Nephrol 1996; 7: 745-750
20. Van Olden RW, van Acker BAC, Koomen GCM, Krediet RT, Arisz L. The time course of inulin and creatinine clearance in the interval between two hemodialysis treatments. Nephrol Dial Transplant 1995; 10: 2274-2280
21. Li P K-T, Chow K-M, Wong T Y-H, Leung C-B, Szeto C-C. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Ann Intern Med 2003; 139: 105-112
22. Van Olden RW, Guchelaar H-J, Struijk DG, Krediet RT, Arisz L. Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int 2003; 23: 339-347
23. Medcalf JF, Harris KPG, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 2001; 59: 1128-1133
24. Schoots AC, Mikkers FEP, Claessens HA, de Smet R, van Landschoot N, Ringair SMG. Characterization of uremic 'middle molecule' fractions by gas chromatography mass spectrometry, isotachophoresis, and liquid chromotography. Clin Chem 1982; 28: 45-49
25. Schoots AC, Dijkstra JB, Ringair SMG, Vanholder R, Cramers CAMG. Are the classical markers sufficient to describe uremic solute accumulation in dialyzed patients? Hippurates reconsidered. Clin Chem 1988; 34: 1022-1029
26. Schoots AC. Multicomponent analysis of accumulated solutes in uremia. Thesis, Technical University of Eindhoven, The Netherlands, 1988
27. Bargman JM, Thorpe KE, Churchill DN, for the CANUSA peritoneal dialysis study group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162
28. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT, for the NECOSAD study group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302
29. Termorsmhuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT, for the NECOSAD study group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004; 15: 1061-1070
30. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320
31. Lo W-K, Ho Y-W, Li C-S et al. Effects of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64: 649-656
32. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med 2002; 347: 2010-2019
33. Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-564
34. Jansen MAM, Hart AAM, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, for the NECOSAD study group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046-1053
35. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002; 61: 256-265
36. Rottembourg J, Issad B, Gallego JL et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Ass 1983; 19: 397-403
37. Cancarini GC, Brunori G, Camerini C et al. Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 1986; 6: 77-79
38. Lysaght MJ, Vonesh EF, Gotch F et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598-604
39. Misra M, Vonesh E, van Stone JC et al. Effect of cause and time of dropout on the residual GFR: A comparative analysis of the decline of GFR on dialysis. Kidney Int 2002; 59: 754-763
40. Lang SM, Bergner A, Topfer M et al. Preservation of residual renal function in dialysis patients: Effect of dialysis-technique related factors. Perit Dial Int 2001; 21: 52-57
41. Shin SK, Noh H, Kang SW et al. Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19: 138-142
42. Carumelo C, Alcuzar R, Gallar P et al. Choice of dialysis membrane does not influence the outcome of residual renal function in hemodialysis patients. Nephrol Dial Transplant 1994; 9: 675-677
43. McCarthy JT, Jenson BM, Squillace DP et al. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. Am J Kidney Dis 1997; 29: 576-583
44. Hartmann J, Fricke H, Schiffl H. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis 1997; 30: 366-373
45. Hiroshige K, Yun K, Soejima M et al. Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int 1996; 16: 307-315
46. De Fijter CW, ter Wee PM, Donkers AJ. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 2000; 15: 1094-1096
47. Fenton SSA, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334-342
48. Korevaar JC, Feith GW, Dekker FW et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int 2003; 64: 2222-2228
49. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT, for the Netherlands Cooperative Study on the Adequacy of Dialysis study group. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: analysis of the Netherlands cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003; 14: 2851-2860